Comparison of efficacy and toxicity between gemcitabine plus carboplatin and gemcitabine plus cisplatin in the treatment of advanced non-small cell lung cancer

Chinese Journal of Lung Cancer

Volumn 5, Issue 6, 2002, Pages 427-428

  Cai, Xiaohong ^a   Chen, Ping ^a   Yin, Xude ^a   Li, Qiu ^a  

^a SICHUAN CANCER HOSPITAL   (China)

Author keywords

Carboplatin; Chemotherapy; Cisplatin; Gemcitabine; NSCLC

Indexed keywords

CARBOPLATIN; CISPLATIN; GEMCITABINE;

ADULT; AGED; ALOPECIA; ANEMIA; ARTICLE; BONE MARROW SUPPRESSION; CANCER DIAGNOSIS; CANCER PATIENT; CLINICAL ARTICLE; CONTROLLED STUDY; DRUG EFFICACY; DYSPNEA; FEMALE; GASTROINTESTINAL DISEASE; HISTOLOGY; HUMAN; KIDNEY DISEASE; LEUKOPENIA; LIVER DISEASE; LUNG NON SMALL CELL CANCER; MALE; NAUSEA; RASH; SIDE EFFECT; THROMBOCYTOPENIA; VOMITING;

EID: 0036923412     PISSN: 10093419     EISSN: 19996187     Source Type: Journal    
DOI: None     Document Type: Article

References (7)

1. Chevalier T, Brisgand P, Douillard JY, et al. Randomized study of vinorelbine and cisplatin versus vindesine and cisplatin versus vinorelbine alone in advanced non-small cell lung cancer: Results of a European multicenter trial including 612 patients. J Clin Oncol, 1994,12(2):360-367.
2. Manegold C, Bergmann B, Chemaissani A, et al. Single-agent gemcitabine versus cisplatin-eloposide: Early results of a randomized phase II study in locally advanced or metastatic non-small cell lung cancer. Ann Oncol, 1997,8(6):525-529.
3. Perng RP, Chen YM, Ming-Liu J, et al. Gemcitabine versus the combination of cisplatin and etoposide in patients with inoperable non-small cell lung cancer in a phase II randomized study. J Clin Oncol, 1997,15(5):2097-2102.
4. Soto Pparra HJ, Cavina R, Antonelli G, et al. Superiority of three week vs four week schedule of cisplatin (CDDP) and gemcitabine (GEM): Results of a randomized phase II study. Lung Cancer, 2000,29(Suppl):48.
5. Gandara DR, Lau DH, Lara PN Jr, et al. Gemcitabine/carboplatin combination regimens: Importance of dose schedule. Oncology (Huntington),2000,14(7 Suppl 4):26-30.